US 11065332
Combination therapy of immunotoxin and checkpoint inhibitor
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11065332 (Combination therapy of immunotoxin and checkpoint inhibitor) held by The Government of The United States as Represented by the Secretary of Health and Human Services, National Institutes of Health expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of The United States as Represented by the Secretary of Health and Human Services, National Institutes of Health
- Grant date
- Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/164, A61K39/395